Typhoid Vaccine (Vi Polysaccharide And Conjugate) Suppliers & Bulk Manufacturers
Available Forms: Injectable suspension (IM), Capsules (oral, live attenuated)
Available Strengths: 0.5 mL
Reference Brands: Typhim Vi. Vivotif (US)
Category: Vaccines
Typhoid Vaccine (Vi Polysaccharide and Conjugate) is available in Injectable suspension (IM), Capsules (oral, live attenuated) and strengths such as 0.5 mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Typhoid Vaccine (Vi Polysaccharide and Conjugate) is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Typhoid Vaccine (Vi Polysaccharide and Conjugate) can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Product Description: Typhoid Vi polysaccharide and conjugate vaccines are approved in both the US and EU, supported by dossiers demonstrating safety, efficacy, and manufacturing quality in accordance with GMP and IVDR standards. In the US, FDA approval involves rigorous clinical evaluation, while in the EU, CE marking certifies conformity with in vitro diagnostic regulations. These vaccines undergo validation, stability testing, and comprehensive audits, with detailed documentation including safety profiles, clinical trial data, and manufacturing practices. For licensing procedures, approved dossiers, and the latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to safe, effective typhoid immunization solutions worldwide, vital for disease prevention and outbreak control.
Frequently Asked Questions
Related Products
Inactivated Vaccines
Strength:
Dose and concentration depend on formulations
Form: Injectable suspension (IM administration), Lyophilized powder for reconstitution
Reference Brands: Sinovac Coronavac. Covaxin(EU)
View Details
Viral Vector Vaccines
Strength:
0.5 mL
Form: Intramuscular injectable suspension (IM)
Reference Brands: US: Johnson & Johnson’s Janssen (Jcovden)
View Details
Mrna-Based Vaccines
Strength:
30 µg and 100 µg
Form: Injectable suspension
Reference Brands: Comirnaty, Spikevax(US)
View Details
Meningococcal Vaccine
Strength:
0.5 mL
Form: Vial or pre-filled syringe (injectable), Conjugate vaccines
Reference Brands: Menactra, Menveo(US)
View DetailsQuick Response Guaranteed | Verified Suppliers
